| August 20, 2025 | Confidentiality Agreement |
| August 20, 2025 | Directors Irrevocable Undertaking - Golumbeski |
| August 20, 2025 | Directors Irrevocable Undertaking - Hickey |
| August 20, 2025 | Directors Irrevocable Undertaking - Jackson |
| August 20, 2025 | Directors Irrevocable Undertaking - Loew |
| August 20, 2025 | Directors Irrevocable Undertaking - Minegishi |
| August 20, 2025 | Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share |
| August 20, 2025 | Rule 2.7 Announcement |
| August 20, 2025 | Rule 2.10 Announcement - Employees |
| August 20, 2025 | Rule 2.10 Announcement - Shareholders |
| August 20, 2025 | Transaction Agreement |
| August 20, 2025 | XRA 5 - Bylaws |
| August 20, 2025 | XRA 5 - Certificate of Incorporation |